Clinical trials
Phase 1 Meningitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2018 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor College of Medicine | 2 |
| Alkermes, Inc. | 1 |
| Centre Hospitalier Universitaire Dijon | 1 |
| Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia | 1 |
| Hualan Biological Engineering, Inc. | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| InventVacc Biologicals Inc. | 1 |
| JN-International Medical Corporation | 1 |
| Janssen Research & Development, LLC | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Meningitis | 13 |
| AIDS-Related Opportunistic Infections | 2 |
| Acquired Immunodeficiency Syndrome | 2 |
| Central Nervous System Infections | 2 |
| HIV Infections | 2 |
| Meningeal Carcinomatosis | 2 |
| Meningitis, Cryptococcal | 2 |
| Meningococcal Infections | 2 |
| Benign Paroxysmal Positional Vertigo | 1 |
| Cryptococcosis | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.